Session Wrap-up: 2026 Updates on β-Blockers in Coronary Artery Disease


The eleventh installment of the 2026 Asian Cardiovascular Disease Series of Web Seminars was successfully convened on November 17, 2026, from 19:00 to 20:30 Beijing Time (5:00–6:30 Mexico Time). Focusing on the theme "Dialogue Between Chinese and Foreign Experts – 2026 Updates on β-Blockers in Coronary Artery Disease," this parallel session brought together prominent specialists from China and Mexico.

Chaired by Prof. Maomao Zhang (CN), the event kicked off with opening remarks. The agenda subsequently highlighted two keynote presentations, featuring a talk on "Beta-Blockers: A Cornerstone of Heart Failure Therapy" by Prof. Jose Antonio Magaña (MX) alongside an in-depth exploration by Prof. Dengfeng Gao (CN) on the "Evidence-Based Benefits of Beta-Blockers in the Standardized Treatment of Coronary Artery Disease."A lively panel discussion, steered by Prof. Wei Song (CN) and Prof. Yang Cao (CN), drove critical conversations on optimizing beta-blocker positioning across the full cardiovascular continuum. The panelists also delved into the clinical advantages of highly selective and long-acting formulations, as well as practical strategies to bridge real-world gaps in dose attainment and long-term adherence. The webinar drew to a close with concluding remarks from Prof. Jingbo Hou (CN), highlighting the key messages from this cross-border dialogue.

Click here to review the full session replay. We look forward to continuing our mission of delivering the latest advancements in cardiovascular medicine.